Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Amarin Corporation plc AMRN

Healthcare Biotechnology
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult... see more

Recent & Breaking News (NDAQ:AMRN)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amarin Corporation Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2021 - AMRN

Newsfile November 8, 2021

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Newsfile November 8, 2021

LAWSUITS FILED AGAINST APPH, AMRN and ONTF - Jakubowitz Law Pursues Shareholders Claims

Accesswire November 8, 2021

Latest Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) to be Presented at American Heart Association Scientific Sessions 2021

GlobeNewswire November 8, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BMRN, AMRN and RECAF

Accesswire November 8, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amarin Corporation plc - AMRN

Newsfile November 7, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HNST, BMRN and AMRN

Accesswire November 7, 2021

ROSEN, A TOP RANKED LAW FIRM, Encourages Amarin Corporation plc Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMRN

PR Newswire November 5, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of APPH, AMRN and CEI

Accesswire November 5, 2021

INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Newsfile November 5, 2021

CLASS ACTION UPDATE for HYZN, AMRN and CEI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire November 5, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, CEI and TMC

Accesswire November 5, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HYZN, INNV and AMRN

Accesswire November 4, 2021

INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Newsfile November 4, 2021

CLASS ACTION UPDATE for NNOX, INNV and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire November 4, 2021

SHAREHOLDER ALERT: BMRN AMRN RECAF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire November 4, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amarin Corporation plc - AMRN

PR Newswire November 3, 2021

LAWSUITS FILED AGAINST BMRN, AMRN and CEI - Jakubowitz Law Pursues Shareholders Claims

Accesswire November 3, 2021

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Newsfile November 3, 2021

CLASS ACTION UPDATE for AMRN, RECAF and CEI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire November 3, 2021